doi:10.1023/A:1024931311845 PMID:12910291 Korkushko OV, Khavinson VKh, Shatilo VB, Antonyk-Sheglova IA
[2] TrimRx's compounded formats give patients more entry points at lower price tiers
Arrhythmia risk may be lowered, by better glycemic control and a decrease in obesity-related cardiovascular risk factors
Consider: Working with a registered dietitian for personalized nutrition counseling Engaging in behavioral weight management programs or support groups Addressing emotional eating patterns and developing alternative coping strategies Setting realistic expectations and defining success beyond the number on the scale Establishing regular self-weighing (weekly) to detect early weight regain and prompt intervention Some patients may benefit from transitioning to alternative pharmacological therapies rather than complete cessation of medication support
Br J Pharmacol 179(4):557570 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018a) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
vrijwel al dat bewijs komt uit dieronderzoek